| NDC Code | 0074-3290-13 |
|---|
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0074-3290-13) |
|---|
| Product NDC | 0074-3290 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Tarka |
|---|
| Non-Proprietary Name | Trandolapril And Verapamil Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 19961022 |
|---|
| End Marketing Date | 20210818 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA020591 |
|---|
| Manufacturer | AbbVie Inc. |
|---|
| Substance Name | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE |
|---|
| Strength | 4; 240 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
|---|